Using data to improve HIV care in Kenya
Part of Immune system & allergy, Infections clinical trials.
This trial is looking at how to improve HIV care by using data and interviews to help clinics make better decisions. It doesn't require you to do anything different—your regular clinic data will be used to see how well appointments are kept.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be receiving HIV care through the AMPATH program in Eldoret, Kenya.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program that offers HIV testing and connects people to prevention or care right in the Emergency Department. It aims to make it easier for anyone visiting the ER to get the HIV services they need.
This trial aims to improve HIV prevention and treatment for pregnant adolescents and young women in Tanzania. It includes reviewing medical records, talking to patients and providers, and testing new care approaches.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
This study looks at ways to improve HIV testing for people who come to the emergency room in Kenya. It is for healthcare workers and patients at certain public hospitals.
This study tests a program to help people living with HIV who have difficulty taking their medications consistently. The goal is to see if extra support can improve health outcomes.
Hear when a new Treatment Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.